FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizonal rule
CBER links to product areas
CBER links
horizonal rule

Product Approval Information - New Drug Applications

horizonal rule

Product name: Anticoagulant Citrate Phosphate Double Dextrose (CP2D) & Additive Solution 3 (AS-3)
Manufacturer: Haemonetics Corp, Union, SC
Indication for Use: To be used only with automated apheresis devices for collecting human blood and blood componenets
Approval Date: 1/18/2002
Type of submission: New Drug application

Approval Letter - (Text), (PDF)

SBA - (Text), (PDF)

 

Updated March 29, 2002
 
horizonal rule

CBER Home Page | CBER A-Z Index | CBER Search | Contact CBER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA / Center for Biologics Evaluation and Research